T86.21 Heart transplant rejection

Name of the Condition

• Heart transplant rejection

Summary

Heart transplant rejection refers to the immune system's response to a transplanted heart, where the body recognizes the organ as foreign and attempts to attack it. This can impair the heart's function and may require prompt intervention to preserve graft viability and patient outcomes.

Causes

Rejection typically results from the immune system's response to the transplanted organ, driven by differences in human leukocyte antigens (HLAs) between the donor and recipient. Acute rejection may occur within weeks to months, while chronic rejection develops over time due to ongoing immune activity or vascular damage.

Risk Factors

• History of prior organ rejection or transplant complications
• Non-adherence to immunosuppressive medications
• Mismatched donor-recipient HLA compatibility
• Pre-existing infections or comorbidities (e.g., diabetes, hypertension)
• Advanced age or poor overall health status

Symptoms

• Fatigue or unexplained weakness
• Shortness of breath or dyspnea
• Swelling in the legs or ankles (edema)
• Rapid or irregular heartbeat (palpitations)
• Persistent fever or flu-like symptoms
• Decreased exercise tolerance
• Unexplained weight gain

Diagnosis

Diagnosis involves clinical evaluation, including physical examination and review of symptoms. Endomyocardial biopsy remains the gold standard for detecting cellular rejection, while non-invasive methods like echocardiography, cardiac MRI, or biomarkers (e.g., troponins) may support assessment. Regular monitoring is critical for early detection.

Treatment Options

Treatment depends on rejection type and severity. Acute cellular rejection may be managed with increased immunosuppression (e.g., corticosteroids, antithymocyte globulin), while antibody-mediated rejection often requires plasmapheresis, intravenous immunoglobulin, or rituximab. Chronic rejection may involve adjustments to long-term immunosuppressive regimens or consideration of retransplantation.

Prognosis and Follow-Up

Prognosis varies based on rejection type, timing, and response to treatment. Early detection and intervention improve outcomes, but recurrent or severe rejection can lead to graft failure. Lifelong immunosuppression and regular follow-up (e.g., biopsies, imaging) are essential to monitor for recurrence and manage side effects.

Complications

• Graft failure or dysfunction
• Infection due to immunosuppression
• Cardiovascular events (e.g., arrhythmias, heart failure)
• Kidney or liver toxicity from medications
• Malignancy (e.g., post-transplant lymphoproliferative disorder)

Lifestyle & Prevention

• Strict adherence to immunosuppressive medication schedules
• Avoidance of infections (e.g., vaccinations, hygiene)
• Regular exercise and heart-healthy diet (as advised)
• Limiting alcohol and avoiding smoking
• Monitoring for symptoms and reporting changes promptly

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden shortness of breath or chest pain
• Severe fatigue or dizziness
• Unexplained weight gain or swelling
• Persistent fever or signs of infection
• Changes in heart rate or rhythm

Tips for Medical Coders

Code T86.21 is specific to heart transplant rejection. Document the type (acute/chronic), timing (e.g., early vs. late), and any contributing factors (e.g., non-adherence, infection) to support accurate coding. Ensure differentiation from other transplant complications (e.g., infection, graft failure) using clinical details.